Hameln Rds Gmbh Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HAMELN RDS GMBH, and what generic and branded alternatives to HAMELN RDS GMBH drugs are available?
HAMELN RDS GMBH has one approved drug.
Drugs and US Patents for Hameln Rds Gmbh
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hameln Rds Gmbh | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 090663-002 | Sep 10, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Hameln Rds Gmbh | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 090663-001 | Sep 10, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.